Simplex Trading’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31.6M | Sell |
89,800
-27,400
| -23% | -$9.77M | 0.02% | 320 |
|
|
2025
Q4 | $38.4M | Buy |
117,200
+13,100
| +13% | +$4.16M | 0.02% | 346 |
|
|
2025
Q3 | $29.4M | Sell |
104,100
-5,900
| -5% | -$1.71M | 0.02% | 492 |
|
|
2025
Q2 | $30.7M | Sell |
110,000
-121,000
| -52% | -$34.3M | 0.02% | 407 |
|
|
2025
Q1 | $72M | Sell |
231,000
-36,400
| -14% | -$10.7M | 0.05% | 192 |
|
|
2024
Q4 | $69.7M | Buy |
267,400
+54,800
| +26% | +$16.3M | 0.04% | 233 |
|
|
2024
Q3 | $68.5M | Buy |
212,600
+9,300
| +5% | +$3.04M | 0.04% | 233 |
|
|
2024
Q2 | $63.5M | Sell |
203,300
-104,300
| -34% | -$30.6M | 0.04% | 254 |
|
|
2024
Q1 | $87.5M | Buy |
307,600
+43,300
| +16% | +$12.7M | 0.05% | 203 |
|
|
2023
Q4 | $76.1M | Buy |
264,300
+32,600
| +14% | +$8.88M | 0.05% | 237 |
|
|
2023
Q3 | $62.3M | Buy |
231,700
+20,100
| +9% | +$5.02M | 0.05% | 232 |
|
|
2023
Q2 | $47M | Sell |
211,600
-80,600
| -28% | -$18.7M | 0.04% | 288 |
|
|
2023
Q1 | $70.6M | Buy |
292,200
+112,600
| +63% | +$27.6M | 0.06% | 216 |
|
|
2022
Q4 | $47.2M | Buy |
179,600
+30,000
| +20% | +$8.04M | 0.05% | 286 |
|
|
2022
Q3 | $33.7M | Sell |
149,600
-51,200
| -25% | -$12.4M | 0.04% | 345 |
|
|
2022
Q2 | $48.9M | Buy |
200,800
+50,400
| +34% | +$12.4M | 0.05% | 252 |
|
|
2022
Q1 | $36.4M | Buy |
150,400
+42,800
| +40% | +$9.83M | 0.03% | 365 |
|
|
2021
Q4 | $24.2M | Buy |
107,600
+600
| +0.6% | +$127K | 0.02% | 441 |
|
|
2021
Q3 | $26.4M | Buy |
107,000
+800
| +0.8% | +$184K | 0.02% | 382 |
|
|
2021
Q2 | $25.9M | Buy |
+106,200
| New | +$26.1M | 0.03% | 374 |
|
|
2021
Q1 | – | Sell |
-1,071
| Closed | -$13.4M | – | 8706 |
|
|
2020
Q4 | $13.4M | Buy |
1,071
+110
| +11% | +$25.4K | 0.02% | 471 |
|
|
2020
Q3 | $24.4M | Sell |
961
-111
| -10% | -$27.5K | 0.03% | 283 |
|
|
2020
Q2 | $25.3M | Buy |
1,072
+503
| +88% | +$115K | 0.04% | 251 |
|
|
2020
Q1 | $11.5M | Sell |
569
-227
| -29% | -$49.6K | 0.02% | 363 |
|
|
2019
Q4 | $19.2M | Sell |
796
-204
| -20% | -$45K | 0.04% | 285 |
|
|
2019
Q3 | $19.4M | Sell |
1,000
-688
| -41% | -$132K | 0.06% | 247 |
|
|
2019
Q2 | $31.1M | Buy |
1,688
+217
| +15% | +$38.9K | 0.08% | 145 |
|
|
2019
Q1 | $27.9M | Buy |
1,471
+452
| +44% | +$86.3K | 0.08% | 158 |
|
|
2018
Q4 | $19.8M | Sell |
1,019
-834
| -45% | -$163K | 0.06% | 207 |
|
|
2018
Q3 | $38.4M | Buy |
1,853
+606
| +49% | +$119K | 0.12% | 111 |
|
|
2018
Q2 | $23M | Sell |
1,247
-545
| -30% | -$96.4K | 0.09% | 152 |
|
|
2018
Q1 | $641K | Buy |
1,792
+83
| +5% | +$15.2K | 0.03% | 591 |
|
|
2017
Q4 | $797K | Sell |
1,709
-1,447
| -46% | -$256K | 0.03% | 492 |
|
|
2017
Q3 | $2.37M | Buy |
3,156
+541
| +21% | +$95.9K | 0.1% | 159 |
|
|
2017
Q2 | $1.57M | Sell |
2,615
-820
| -24% | -$133K | 0.07% | 229 |
|
|
2017
Q1 | $897K | Buy |
3,435
+1,648
| +92% | +$274K | 0.04% | 423 |
|
|
2016
Q4 | $839K | Sell |
1,787
-107
| -6% | -$16.1K | 0.05% | 316 |
|
|
2016
Q3 | $584K | Buy |
1,894
+882
| +87% | +$149K | 0.04% | 445 |
|
|
2016
Q2 | $532K | Sell |
1,012
-801
| -44% | -$125K | 0.04% | 497 |
|
|
2016
Q1 | $685K | Buy |
1,813
+652
| +56% | +$96.9K | 0.05% | 327 |
|
|
2015
Q4 | $964K | Sell |
1,161
-1,170
| -50% | -$184K | 0.08% | 227 |
|
|
2015
Q3 | $628K | Buy |
2,331
+566
| +32% | +$89.2K | 0.05% | 365 |
|
|
2015
Q2 | $772K | Buy |
1,765
+326
| +23% | +$52.2K | 0.06% | 267 |
|
|
2015
Q1 | $830K | Buy |
+1,439
| New | +$227K | 0.1% | 198 |
|
Other funds holding AMGN
VCM
VPM
Simplex Trading's AMGN Position: Q4 2025 in Review
Simplex Trading sold out of Amgen (AMGN) in Q4 2025, closing a stake of 4,602 shares — an estimated $1.46M sold.
Simplex Trading first reported a position in AMGN in Q4 2014 and held it in 22 quarters. The position peaked at $32.3M in Q2 2017. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- Simplex Trading reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 4,602 Amgen shares in Q4 2025, an estimated $1.46M.
- Simplex Trading first reported a position in Amgen in Q4 2014 and held it in 22 quarters.
- Simplex Trading's Amgen position peaked at $32.3M in Q2 2017.
- 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.